Click on a filter below to refine your search. Remove a filter to broaden your search.
The drug company says that its new mRNA vaccine produces an immune response against the BA.4 and BA.5 omicron subvariants.
CDC says smaller packages of the vaccine may be available by October
Vaccine effectiveness for all three vaccines decreased from 91 percent in months preceding delta predominance